Updated on 2024/03/25

写真a

 
AMAIKE Kazuma
 
Organization
Research Center for Materials Science Assistant Professor
Graduate School
Graduate School of Science
Title
Assistant Professor
External link

Degree 1

  1. 博士(理学) ( 2016.3   名古屋大学 ) 

 

Papers 22

  1. Nickel/Photoredox-Catalyzed Decarboxylative Coupling of Aryl Bromides with N -Protected Glycine as an Aminomethyl Source

    Jung, JHY; Kinoshita, T; Makihara, Y; Sakakibara, Y; Amaike, K; Murakami, K; Itami, K

    SYNLETT   Vol. 35 ( 03 ) page: 337 - 341   2024.2

     More details

    Publisher:Synlett  

    Benzylamines are important scaffolds that are ubiquitously found in various bioactive molecules. Among the benzylamine derivatives, primary benzylamines (ArCH2NH2) are regarded as valuable building blocks for pharmaceuticals. Herein, we report decarboxylative aminomethylation of aryl bromides with N-protected glycine under nickel/photoredox-catalyzed conditions. The corresponding products can be easily deprotected under acidic conditions to give primary benzylamines.

    DOI: 10.1055/s-0041-1738444

    Web of Science

    Scopus

  2. C-H arylation enables synthesis of imidazole-4-carboxamide (ICA) based fairy chemicals with plant growth promoting activity

    Ayaka Ueda, Kazuma Amaike, Yoko Shirotani, Robin Warstat, Hideto Ito, Jae-Hoon Choi, Hirokazu Kawagishi, Kenichiro Itami

    Canadian Journal of Chemistry   Vol. 101 ( 7 ) page: 449 - 452   2023.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Canadian Science Publishing  

    Imidazole-4-carboxamide (ICA), which is one of a group of “fairy chemicals” (FCs) that cause the fairy ring phenomena, has plant growth inhibitory activity. FCs have the potential as candidates for a new family of plant hormones as they have been found endogenously in all plant species tested, and show growth-regulating activity against the plants. While basic research on FCs is progressing, they are also expected to be applied not only to agrochemicals but also as pharmaceuticals. Derivatization of one of FCs, 2-azahypoxanthine (AHX) and the structure-activity relationship (SAR) studies have clarified its activity as a plant growth promoter. Yet, imidazole-4-carboxamide (ICA) has not been derivatized at all and SAR regarding its activity remains unknown. In this study, we synthesized the derivatives of ICA by direct C-H arylation of ICA precursors and evaluated its activity in rice. The 12 total compounds including the arylated ICAs and their precursors were evaluated for root and shoot elongation in rice, resulting in the discovery that a number of compounds unexpectedly have an elongation activity in the root and shoot.

    DOI: 10.1139/cjc-2022-0256

    Web of Science

    Scopus

  3. Development of a novel PET ligand, [<SUP>11</SUP>C]GO289 targeting CK2 expressed in the brain

    Ogata, A; Yamada, T; Hattori, S; Ikenuma, H; Abe, J; Tada, M; Ichise, M; Suzuki, M; Ito, K; Kato, T; Amaike, K; Hirota, T; Kakita, A; Itami, K; Kimura, Y

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   Vol. 90   page: 129327   2023.6

     More details

    Language:English   Publisher:Bioorganic and Medicinal Chemistry Letters  

    Positron emission tomography (PET) is a powerful imaging tool that enables early in vivo detection of Alzheimer's disease (AD). For this purpose, various PET ligands have been developed to image β-amyloid and tau protein aggregates characteristically found in the brain of AD patients. In this study, we initiated to develop another type of PET ligand that targets protein kinase CK2 (formerly termed as casein kinase II), because its expression level is known to be altered in postmortem AD brains. CK2 is a serine/threonine protein kinase, an important component of cellular signaling pathways that control cellular degeneration. In AD, the CK2 level in the brain is thought to be elevated by its involvement in both phosphorylation of proteins such as tau and neuroinflammation. Decreased CK2 activity and expression levels lead to β-amyloid accumulation. In addition, since CK2 also contributes to the phosphorylation of tau protein, the expression level and activity of CK2 is expected to undergo significant changes during the progression of AD pathology. Furthermore, CK2 could act as a potential target for modulating the inflammatory response in AD. Therefore, PET imaging targeting CK2 expressed in the brain could be a useful another imaging biomarker for AD. We synthesized and radiolabeled a CK2 inhibitor, [11C]GO289, in high yields from its precursor and [11C]methyl iodide under basic conditions. On autoradiography, [11C]GO289 specifically bound to CK2 in both rat and human brain sections. On baseline PET imaging, this ligand entered and rapidly washed out of the rat brain with its peak activity rather being small (SUV < 1.0). However, on blocking, there was no detectable CK2 specific binding signal. Thus, [11C]GO289 may be useful in vitro but not so in vivo in its current formulation. The lack of detectable specific binding signal in the latter may be due to a relatively high component of nonspecific binding signal in the overall rather weak PET signal, or it may also be related to the known fact that ATP can competitively binds to subunits of CK2, reducing its availability for this ligand. In the future, it will be necessary for PET imaging of CK2 to try out different non-ATP competitive formulations of CK2 inhibitor that can also provide significantly higher in vivo brain penetration.

    DOI: 10.1016/j.bmcl.2023.129327

    Web of Science

    Scopus

    PubMed

  4. Revisiting PFA-mediated tissue fixation chemistry: FixEL enables trapping of small molecules in the brain to visualize their distribution changes

    Nonaka Hiroshi, Mino Takeharu, Sakamoto Seiji, Oh Jae Hoon, Watanabe Yu, Ishikawa Mamoru, Tsushima Akihiro, Amaike Kazuma, Kiyonaka Shigeki, Tamura Tomonori, Radu Aricescu A., Kakegawa Wataru, Miura Eriko, Yuzaki Michisuke, Hamachi Itaru

    Chem   Vol. 9 ( 2 ) page: 523 - 540   2023.2

     More details

    Language:English  

    Various small molecules have been used as functional probes for tissue imaging in medical diagnosis and pharmaceutical drugs for disease treatment. The spatial distribution, target selectivity, and diffusion/excretion kinetics of small molecules in structurally complicated specimens are critical for function. However, robust methods for precisely evaluating these parameters in the brain have been limited. Herein, we report a new method termed “fixation-driven chemical cross-linking of exogenous ligands (FixEL), ” which traps and images exogenously administered molecules of interest (MOIs) in complex tissues. This method relies on protein-MOI interactions and chemical cross-linking of amine-tethered MOI with paraformaldehyde used for perfusion fixation. FixEL is used to obtain images of the distribution of the small molecules, which addresses selective/nonselective binding to proteins, time-dependent localization changes, and diffusion/retention kinetics of MOIs such as the scaffold of PET tracer derivatives or drug-like small molecules.

    CiNii Research

  5. Revisiting PFA-mediated tissue fixation chemistry:<i> FixEL</i> enables trapping of small molecules in the brain to visualize their distribution changes

    Nonaka Hiroshi, Mino Takeharu, Sakamoto Seiji, Oh Jae Hoon, Watanabe Yu, Ishikawa Mamoru, Tsushima Akihiro, Amaike Kazuma, Kiyonaka Shigeki, Tamura Tomonori, Aricescu A. Radu, Kakegawa Wataru, Miura Eriko, Yuzaki Michisuke, Hamachi Itaru

    CHEM   Vol. 9 ( 2 ) page: 523 - 540   2023.2

     More details

    Publisher:Chem  

    Various small molecules have been used as functional probes for tissue imaging in medical diagnosis and pharmaceutical drugs for disease treatment. The spatial distribution, target selectivity, and diffusion/excretion kinetics of small molecules in structurally complicated specimens are critical for function. However, robust methods for precisely evaluating these parameters in the brain have been limited. Herein, we report a new method termed “fixation-driven chemical cross-linking of exogenous ligands (FixEL),” which traps and images exogenously administered molecules of interest (MOIs) in complex tissues. This method relies on protein-MOI interactions and chemical cross-linking of amine-tethered MOI with paraformaldehyde used for perfusion fixation. FixEL is used to obtain images of the distribution of the small molecules, which addresses selective/nonselective binding to proteins, time-dependent localization changes, and diffusion/retention kinetics of MOIs such as the scaffold of PET tracer derivatives or drug-like small molecules.

    DOI: 10.1016/j.chempr.2022.11.005

    Web of Science

    Scopus

  6. Discovery of 2,6-Dihalopurines as Stomata Opening Inhibitors: Implication of an LRX-Mediated H plus -ATPase Phosphorylation Pathway

    Ueda, A; Aihara, Y; Sato, S; Kano, K; Mishiro-Sato, E; Kitano, H; Sato, A; Fujimoto, KJ; Yanai, T; Amaike, K; Kinoshita, T; Itami, K

    ACS CHEMICAL BIOLOGY   Vol. 18 ( 2 ) page: 347 - 355   2023.1

     More details

    Language:English   Publisher:ACS Chemical Biology  

    Stomata are pores in the leaf epidermis of plants and their opening and closing regulate gas exchange and water transpiration. Stomatal movements play key roles in both plant growth and stress responses. In recent years, small molecules regulating stomatal movements have been used as a powerful tool in mechanistic studies, as well as key players for agricultural applications. Therefore, the development of new molecules regulating stomatal movement and the elucidation of their mechanisms have attracted much attention. We herein describe the discovery of 2,6-dihalopurines, AUs, as a new stomatal opening inhibitor, and their mechanistic study. Based on biological assays, AUs may involve in the pathway related with plasma membrane H+-ATPase phosphorylation. In addition, we identified leucine-rich repeat extensin proteins (LRXs), LRX3, LRX4 and LRX5 as well as RALF, as target protein candidates of AUs by affinity based pull down assay and molecular dynamics simulation. The mechanism of stomatal movement related with the LRXs-RALF is an unexplored pathway, and therefore further studies may lead to the discovery of new signaling pathways and regulatory factors in the stomatal movement.

    DOI: 10.1021/acschembio.2c00771

    Web of Science

    Scopus

    PubMed

  7. Synthesis, properties, and material hybridization of bare aromatic polymers enabled by dendrimer support

    Shusei Fujiki, Kazuma Amaike, Akiko Yagi, Kenichiro Itami

    Nature Communications   Vol. 13 ( 1 ) page: 5358   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Aromatic polymers are the first-choice platform for current organic materials due to their distinct optical, electronic, and mechanical properties as well as their biocompatibility. However, bare aromatic polymer backbones tend to strongly aggregate, rendering them essentially insoluble in organic solvent. While the typical solution is to install many solubilizing substituents on the backbones, this often provokes undesired property changes. Herein, we report the synthesis of bare aromatic polymers enabled by a dendrimer support. An initiator arene containing a diterpenoid-based dendrimer undergoes Pd-catalyzed polymerization with monomers bearing no solubilizing substituents to furnish bare aromatic polymers such as polythiophenes and poly(para-phenylene)s. The high solubility of dendrimer-ligated polymers allows not only the unveiling of the properties of unsubstituted π-conjugated backbone, but also mild release of dendrimer-free aromatic polymers and even transfer of aromatic polymers to other materials, such as silica gel and protein, which may accelerate the creation of hybrid materials nowadays challenging to access.

    DOI: 10.1038/s41467-022-33100-7

    Web of Science

    Scopus

    PubMed

    Other Link: https://www.nature.com/articles/s41467-022-33100-7

  8. Photopharmacological Manipulation of Mammalian CRY1 for Regulation of the Circadian Clock

    Kolarski, Dusan, Miller, Simon, Oshima, Tsuyoshi, Nagai, Yoshiko, Aoki, Yugo, Kobauri, Piermichele, Srivastava, Ashutosh, Sugiyama, Akiko, Amaike, Kazuma, Sato, Ayato, Tama, Florence, Szymanski, Wiktor, Feringa, Ben L., Itami, Kenichiro, Hirota, Tsuyoshi

    Journal of the American Chemical Society   Vol. 143 ( 4 ) page: 2078 - 2087   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/jacs.0c12280

    Web of Science

    Scopus

    PubMed

  9. An Isoform-Selective Modulator of Cryptochrome 1 Regulates Circadian Rhythms in Mammals International journal

    Miller, Simon, Aikawa, Yoshiki, Sugiyama, Akiko, Nagai, Yoshiko, Hara, Aya, Oshima, Tsuyoshi, Amaike, Kazuma, Kay, Steve A., Itami, Kenichiro, Hirota, Tsuyoshi

    Cell Chemical Biology   Vol. 27 ( 9 ) page: 1192 - +   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cryptochrome 1 (CRY1) and CRY2 are core regulators of the circadian clock, and the development of isoform-selective modulators is important for the elucidation of their redundant and distinct functions. Here, we report the identification and functional characterization of a small-molecule modulator of the mammalian circadian clock that selectively controls CRY1. Cell-based circadian chemical screening identified a thienopyrimidine derivative KL201 that lengthened the period of circadian rhythms in cells and tissues. Functional assays revealed stabilization of CRY1 but not CRY2 by KL201. A structure-activity relationship study of KL201 derivatives in combination with X-ray crystallography of the CRY1-KL201 complex uncovered critical sites and interactions required for CRY1 regulation. KL201 bound to CRY1 in overlap with FBXL3, a subunit of ubiquitin ligase complex, and the effect of KL201 was blunted by knockdown of FBXL3. KL201 will facilitate isoform-selective regulation of CRY1 to accelerate chronobiology research and therapeutics against clock-related diseases.

    DOI: 10.1016/j.chembiol.2020.05.008

    Web of Science

    Scopus

    PubMed

  10. Small Molecules Modulating Mammalian Biological Clocks: Exciting New Opportunities for Synthetic Chemistry

    Amaike, Kazuma, Oshima, Tsuyoshi, Skoulding, Nicola Stephanie, Toyama, Yoshifumi, Hirota, Tsuyoshi, Itami, Kenichiro

    Chem   Vol. 6 ( 9 ) page: 2186 - 2198   2020.9

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.chempr.2020.08.011

    Web of Science

    Scopus

  11. Construction of a Fluorescent Screening System of Allosteric Modulators for the GABA(A) Receptor Using a Turn-On Probe Reviewed

    Sakamoto, Seiji, Sakamoto, Seiji, Yamaura, Kei, Yamaura, Kei, Numata, Tomohiro, Numata, Tomohiro, Harada, Fumio, Harada, Fumio, Amaike, Kazuma, Amaike, Kazuma, Inoue, Ryuji, Inoue, Ryuji, Kiyonaka, Shigeki, Kiyonaka, Shigeki, Hamachi, Itaru, Hamachi, Itaru

    ACS Central Science   Vol. 5 ( 9 ) page: 1541 - 1553   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system. The fast inhibitory actions of GABA are mainly mediated by GABA(A) receptors (GABA(A)Rs), which are widely recognized as clinically relevant drug targets. However, it remains difficult to create screening systems for drug candidates that act on GABA A Rs because of the existence of multiple ligand-binding sites and the delicate pentameric structures of GABA(A)Rs. We here developed the first turn-on fluorescent imaging probe for GABA(A)Rs, which can be used to quantitatively evaluate ligand-receptor interactions under live cell conditions. Using noncovalent labeling of GABA(A)Rs with this turn-on probe, a new imaging-based ligand assay system, which allows discovery of positive allosteric modulators (PAMs) for the GABA(A)R, was successfully constructed. Our system is applicable to high-throughput ligand screening, and we discovered new small molecules that function as PAMs for GABA(A)Rs. These results highlight the power of the use of a turn-on fluorescent probe to screen drugs for complicated membrane proteins that cannot be addressed by conventional methods.

    DOI: 10.1021/acscentsci.9b00539

    Web of Science

    Scopus

    PubMed

  12. Synthesis of multiply arylated pyridines Reviewed

    Asako, Takashi, Hayashi, Wakana, Amaike, Kazuma, Suzuki, Shin, Itami, Kenichiro, Muto, Kei, Yamaguchi, Junichiro

    Tetrahedron   Vol. 73 ( 26 ) page: 3669 - 3676   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    We have achieved a synthesis of multiply arylated pyridines by using a [4 + 2] cycloaddition of 2,4-diaryl-5-chloroxazoles and cinnamic acids as a key reaction. The resulting hydroxytriarylpyridines can be derivatized into triarylpyridines, tetraarylpyridines and pentaarylpyridines by sequential cross couplings. This synthetic method allows for facile and rapid access to highly arylated pyridines with different aryl substituents. (C) 2017 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tet.2017.03.095

    Web of Science

    Scopus

  13. Affinity-Guided Oxime Chemistry for Selective Protein Acylation in Live Tissue Systems Reviewed

    Tamura, Tomonori, Song, Zhining, Amaike, Kazuma, Lee, Shin, Yin, Sifei, Kiyonaka, Shigeki, Hamachi, Itaru

    Journal of the American Chemical Society   Vol. 139 ( 40 ) page: 14181 - 14191   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Catalyst-mediated protein modification is a powerful approach for the imaging and engineering of natural proteins. We have previously developed affinity-guided 4-dimethylaminopyridine (AGD) chemistry as an efficient protein modification method using a catalytic acyl transfer reaction. However, because of the high electrophilicity of the thioester acyl donor molecule, AGD chemistry suffers from nonspecific reactions to proteins other than the target protein in crude biological environments, such as cell lysates, live cells, and tissue samples. To overcome this shortcoming, we here report a new acyl donor/organocatalyst system that allows more specific and efficient protein modification. In this method, a highly nucleophilic pyridinium oxime (PyOx) catalyst is conjugated to a ligand specific to the target protein. The ligand-tethered PyOx selectively binds to the target protein and facilitates the acyl transfer reaction of a mild electrophilic N-acyl-N-alkylsulfonamide acyl donor on the protein surface. We demonstrated that the new catalytic system, called AGOX (affinity-guided oxime) chemistry, can modify target proteins, both in test tubes and cell lysates, more selectively and efficiently than AGD chemistry. Low-background fluorescence labeling of the endogenous cell-membrane proteins, carbonic anhydrase XII and the folate receptor, in live cells allowed for the precise quantification of diffusion coefficients in the protein's native environment. Furthermore, the excellent biocompatibility and bioorthogonality of AGOX chemistry were demonstrated by the selective labeling of an endogenous neurotransmitter receptor in mouse brain slices, which are highly complicated tissue samples.

    DOI: 10.1021/JACS.7B07339

    Web of Science

    PubMed

  14. Recognition-driven chemical labeling of endogenous proteins in multi-molecular crowding in live cells Reviewed

    Amaike, Kazuma, Tamura, Tomonori, Hamachi, Itaru

    Chemical Communications   Vol. 53 ( 88 ) page: 11972 - 11983   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    Endogenous protein labeling is one of the most invaluable methods for studying the bona fide functions of proteins in live cells. However, multi-molecular crowding conditions, such as those that occur in live cells, hamper the highly selective chemical labeling of a protein of interest (POI). We herein describe how the efficient coupling of molecular recognition with a chemical reaction is crucial for selective protein labeling. Recognition-driven protein labeling is carried out by a synthetic labeling reagent containing a protein (recognition) ligand, a reporter tag, and a reactive moiety. The molecular recognition of a POI can be used to greatly enhance the reaction kinetics and protein selectivity, even under live cell conditions. In this review, we also briefly discuss how such selective chemical labeling of an endogenous protein can have a variety of applications at the interface of chemistry and biology.

    DOI: 10.1039/C7CC07177A

    Web of Science

    PubMed

  15. Synthesis of Triarylpyridines in Thiopeptide Antibiotics by Using a C-H Arylation/Ring-Transformation Strategy Reviewed

    Amaike, Kazuma, Itami, Kenichiro, Yamaguchi, Junichiro

    Chemistry - A European Journal   Vol. 22 ( 13 ) page: 4384 - 4388   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    We have described a C-H arylation/ring-transformation strategy for the synthesis of triarylpyridines, which form the core structure of thiopeptide antibiotics. This synthetic method readily gave 2,3,6-triarylpyridines in a regioselective manner by a two-phase approach: C-H arylation (a nickel-catalyzed decarbonylative Suzuki-Miyaura cross-coupling and decarbonylative C-H coupling for the synthesis of 2,4-diaryloxazoles) and ring transformation ([4+2] cycloaddition of 2,4-diaryloxazoles with (hetero)arylacrylic acids). To showcase these methods, we have accomplished the formal synthesis of thiopeptide antibiotics GE2270s and amythiamicins.

    DOI: 10.1002/chem.201600351

    Web of Science

    Scopus

    PubMed

  16. Direct C7 Functionalization of Tryptophan. Synthesis of Methyl (S)-2-((tert-Butoxycarbonyl) amino)-3-(7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indol-3-yl)propanoate Reviewed

    Amaike, Kazuma, Loach, Richard P., Movassaghi, Mohammad

    Organic Syntheses   Vol. 92   page: 373 - +   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    DOI: 10.15227/ORGSYN.092.0373

    Web of Science

    PubMed

  17. beta-Selective C-H Arylation of Pyrroles Leading to Concise Syntheses of Lamellarins C and I Reviewed

    Ueda, Kirika, Amaike, Kazuma, Maceiczyk, Richard M., Itami, Kenichiro, Yamaguchi, Junichiro

    Journal of the American Chemical Society   Vol. 136 ( 38 ) page: 13226 - 13232   2014.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The first general beta-selective C-H arylation of pyrroles has been developed by using a rhodium catalyst. This C H arylation reaction, which is retrosynthetically straightforward but results in unusual regioselectivity, could result in de novo syntheses of pyrrole-derived natural products and pharmaceuticals. As such, we have successfully synthesized polycyclic marine pyrrole alkaloids, lamellarins C and I, by using this beta-selective arylation of pyrroles with aryl iodides (C-H/C-I coupling) and a new double C-H/C-H coupling as key steps.

    DOI: 10.1021/ja508449y

    Web of Science

    Scopus

    PubMed

  18. Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues Reviewed

    Sekizawa, Hiromi, Amaike, Kazuma, Itoh, Yukihiro, Suzuki, Takayoshi, Itami, Kenichiro, Yamaguchi, Junichiro

    ACS Medicinal Chemistry Letters   Vol. 5 ( 5 ) page: 582 - 586   2014.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    We previously reported the discovery of NCH-31, a potent histone deacetylase (HDAC) inhibitor. By utilizing our C-H coupling reaction, we rapidly synthesized 16 analogues (IYS-1 through IYS-15 and IYS-Me) of NCH-31 with different aryl groups at the C4-position of 2-aminothiazole core of NCH-31. Subsequent biological testing of these derivatives revealed that 3-fluorophenyl (IYS-10) and 4-fluorophenyl (IYS-15) derivatives act as potent pan-HDAC inhibitor. Additionally, 4-methylphenyl (IYS-1) and 3-fluoro-4-methylphenyl (IYS-14) derivatives acted as HDAC6-insensitive inhibitors. The present work clearly shows the power of the late-stage C H coupling approach to rapidly identify novel and highly active/selective biofunctional molecules.

    DOI: 10.1021/ml500024s

    Web of Science

    Scopus

    PubMed

  19. C7-Derivatization of C3-Alkylindoles Including Tryptophans and Tryptamines Reviewed

    Loach, Richard P., Fenton, Owen S., Amaike, Kazuma, Siegel, Dustin S., Ozkal, Erhan, Movassaghi, Mohammad

    The Journal of Organic Chemistry   Vol. 79 ( 22 ) page: 11254 - 11263   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A versatile strategy for C7-selective boronation of tryptophans, tryptamines, and 3-alkylindoles by way of a single-pot C2/C7-diboronationC2-protodeboronation sequence is described. The combination of a mild iridium-catalyzed C2/C7-diboronation followed by an in situ palladium-catalyzed C2-protodeboronation allows efficient entry to valuable C7-boroindoles that enable further C7-derivatization. The versatility of the chemistry is highlighted by the gram-scale synthesis of C7-boronated N-Boc-L-tryptophan methyl ester and the rapid synthesis of C7-halo, C7-hydroxy, and C7-aryl tryptophan derivatives.

    DOI: 10.1021/JO502062Z

    Web of Science

    PubMed

  20. Nickel-Catalyzed Direct Coupling of Heteroarenes

    Yamaguchi Junichiro, Muto Kei, Amaike Kazuma, Yamamoto Takuya, Itami Kenichiro

    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN   Vol. 71 ( 6 ) page: 576 - 587   2013.6

     More details

    Language:Japanese  

    Web of Science

  21. Nickel-Catalyzed Direct Coupling of Heteroarenes Reviewed

    Yamaguchi, Junichiro, Muto, Kei, Amaike, Kazuma, Yamamoto, Takuya, Itami, Kenichiro

    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry   Vol. 71 ( 6 ) page: 576 - 587   2013

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:SOC SYNTHETIC ORGANIC CHEM JPN  

    Nickel-catalyzed cross-coupling reactions have recently been receiving significant attention from the synthetic community as a way to construct carbon-carbon or carbon-heteroatom bonds, because nickel catalysts are less expensive and less toxic than palladium catalysts.We herein describe our recent developments in nickel-catalyzed biaryl coupling methodology, along with mechanistic studies and applications to the synthesis of natural products and pharmaceuticals. In particular, we focus on nickel-catalyzed direct coupling reactions in which "unreactive" bonds such as C-H, C-O, and C-C bonds are converted into biaryl moieties.

    DOI: 10.5059/YUKIGOSEIKYOKAISHI.71.576

    Web of Science

    Scopus

    CiNii Research

  22. Decarbonylative C-H Coupling of Azoles and Aryl Esters: Unprecedented Nickel Catalysis and Application to the Synthesis of Muscoride A Reviewed

    Amaike, Kazuma, Muto, Kei, Yamaguchi, Junichiro, Itami, Kenichiro

    Journal of the American Chemical Society   Vol. 134 ( 33 ) page: 13573 - 13576   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A nickel-catalyzed decarbonylative C-H biaryl coupling of azoles and aryl esters is described. The newly developed catalytic system does not require the use of expensive metal catalysts or silver- or copper-based stoichiometric oxidants. We have successfully applied this new C-H arylation reaction to a convergent formal synthesis of muscoride A.

    DOI: 10.1021/ja306062c

    Web of Science

    Scopus

    PubMed

▼display all

MISC 1

  1. Synthesis of Natural Products and Pharmaceuticals via Catalytic C-H Functionalization

    Junichiro Yamaguchi, Kazuma Amaike, Kenichiro Itami

    Transition Metal-Catalyzed Heterocycle Synthesis via C-H Activation     page: 505 - 550   2016.1

     More details

    Language:English   Publisher:wiley  

    The synthesis of natural products and pharmaceuticals, particularly those containing heterocyclic frameworks, can be dramatically simplified by using catalytic C-H functionalization. C-H functionalization has gathered significant interest from the organic synthesis community because it provides a new strategy to construct carbon-carbon and carbon-heteroatom bonds in highly functionalized, complex molecules without prefunctionalization. In this book chapter, methods in heterocycle substitution and synthesis using catalytic C-H functionalization are classified by heterocycle, with specific focus on the cutting-edge synthesis of natural products and pharmaceuticals.

    DOI: 10.1002/9783527691920.ch16

    Scopus

KAKENHI (Grants-in-Aid for Scientific Research) 3

  1. 核酸輸送を加速させる一次元伸張ナノカーボン分子の創製

    Grant number:22K14797  2022.4 - 2024.3

    日本学術振興会  科学研究費助成事業  若手研究

    天池 一真

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    核酸輸送はDNAやRNAを外部から宿主細胞に導入することであり、創薬や育種の現場から基礎生物学に至るまで生命科学研究に絶対的に不可欠な技術である。生命現象の理解と制御のさらなる高度化が必要な今、効率や選択性はもちろんのこと生体直交性などの多様な機能が核酸輸送に求められている。核酸輸送の分野に全く新しい方法、キャリア分子群の登場がまたれる所以である。本研究では、哺乳・植物・昆虫を対象とした核酸輸送を加速させるテーラーメイドな核酸輸送ナノカーボン分子を創製することで基礎と応用の両面からこの分野に非線形のブレークスルーをもたらす。
    近年、核酸医薬やゲノム編集技術といった核酸を用いた技術の発展が目覚ましい。これらの技術は基本的に、核酸が核に到達することで機能が発揮されるため、効率的に外部から核酸を輸送することが求められる。しかし生物は細胞膜や細胞壁などの脂溶性の高い物理的な障壁を持つため、電荷を帯びた核酸を細胞内に輸送するのは一般的に困難である。そのため現在においても核酸輸送法の開発、改良が進められている。近年、カチオン性カーボンナノチューブをはじめとする炭素材料(ナノカーボン)が、新たな核酸輸送のための次世代キャリアとして期待が高まっている。しかしその詳細な作用機序、最適なナノカーボンの構造情報は不明のままである。そのため本研究課題では、精密に構造が制御されたナノカーボン分子を合成し、哺乳、植物、昆虫を対象とした構造物性相関研究をおこない、それぞれの生物種に合わせたテーラーメイドなナノカーボン分子の創製をおこなう。分子設計に関しては、細胞外におけるナノカーボン分子と核酸との相互作用、細胞膜、細胞壁の透過能、そして細胞内における核酸の解離を念頭においておこなう。一次元に伸張したナノカーボン分子の合成に関しては共有結合的に伸張させる方法を確立した。すなわち、最近報告したデンドリマーを担体とした芳香族ポリマー(Fujiki et al. Nature Communications 2022, 13, 5358.)に対して、ポリエチレンイミンを作用させることで、一段階で種々の一次元に伸張したナノカーボン分子を合成した。
    近年、カチオン性カーボンナノチューブをはじめとする炭素材料(ナノカーボン)が、新たな核酸輸送のための次世代キャリアとして期待が高まっているものの、その詳細な作用機序、最適なナノカーボンの構造情報は不明のままである。今回、一次元に伸張したナノカーボン分子の合成に関しては共有結合的に伸張させる方法を確立した。すなわち、最近報告したデンドリマーを担体とした芳香族ポリマー(Fujiki et al. Nature Communications 2022, 13, 5358.)に対して、ポリエチレンイミンを作用させることで、一段階で種々の一次元に伸張したカチオン性ナノカーボン分子を合成した。
    複数種類の一次元伸長ナノカーボンを精密に合成できたため、おおむね順調に研究は進行している。
    今年度合成を達成した分子を用いて構造物性相関研究を遂行する。またその結果をもとに、一次元伸長ナノカーボンの骨格デザインや、付与するカチオン性ポリマーを変更し、哺乳類、昆虫、植物それぞれに最適な核酸輸送材料を合成する。

  2. Search and design of compounds with synergistic effects by AI

    Grant number:20H05797  2020.10 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Transformative Research Areas (B)

    Yamanishi Yoshihiro

      More details

    Authorship:Coinvestigator(s) 

    Chemotherapy that utilizes the synergistic effect of a combination of multiple drugs (drug synergy) has been recognized as an effective method for treatment of multifactorial diseases such as cancer and neurodegenerative diseases. This research group develops statistical methods for predicting drug combinationss with synergistic effects, and machine learning methods for outputting structures of new compounds with stronger effects. Specifically, the research will proceed in the following three stages. 1) Development of a method for predicting drug combinations with synergistic effects by fusion analysis of omics data. 2) Network analysis of the mechanism of drug synergy. 3) Developing methods for generating and designing chemical structures of new compounds with higher synergistic effects.

  3. Science of fairy chemicals and their application development

    Grant number:20H05620  2020.7 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Specially Promoted Research

      More details

    Authorship:Coinvestigator(s)